Principal Securities’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$260K Buy
+1,420
New +$262K ﹤0.01% 1271
2025
Q4
Sell
-711
Closed -$99.6K 1580
2025
Q3
$99.6K Buy
711
+7
+1% +$946 ﹤0.01% 1597
2025
Q2
$88.4K Buy
704
+367
+109% +$45.7K ﹤0.01% 1597
2025
Q1
$51.5K Hold
337
﹤0.01% 1751
2024
Q4
$51.5K Buy
337
+78
+30% +$13.2K ﹤0.01% 1750
2024
Q3
$50.2K Sell
259
-11
-4% -$2.3K ﹤0.01% 1691
2024
Q2
$62.6K Sell
270
-8
-3% -$1.74K ﹤0.01% 1517
2024
Q1
$59.9K Sell
278
-173
-38% -$40.5K ﹤0.01% 1489
2023
Q4
$117K Buy
+451
New +$111K ﹤0.01% 1140

Other funds holding BIIB

Principal Securities's BIIB Position: Q1 2026 in Review

Principal Securities opened a new position in Biogen (BIIB) in Q1 2026: 1,420 shares worth $260K. The stake represents ﹤0.01% of the portfolio and ranks #1271 among its holdings. This is a return to the name: Principal Securities previously reported a position in BIIB as recently as Q3 2025.

Principal Securities first reported a position in BIIB in Q4 2023 and has held it in 9 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Principal Securities held 1,420 shares of Biogen worth $260K as of Q1 2026.
  • Biogen was a new Principal Securities position in Q1 2026.
  • Biogen made up ﹤0.01% of Principal Securities's portfolio in Q1 2026, its #1271 holding.
  • Principal Securities first reported a position in Biogen in Q4 2023 and has held it in 9 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Principal Securities's 13F filing for Q1 2026, filed 13 May 2026.